TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31186389

Group type: EXPERIMENTAL
Intervention: Progressive resistance exercises for 60 minutes, two times a week for six months, in addition to standard medical care.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard medical care with no change in regular daily activities.
Number of subjects: 32
Study: 29066877

Group type: EXPERIMENTAL
Intervention: Subcutaneous teriparatide (20 μg/day)
Number of subjects: 362

Group type: COMPARATOR
Intervention: Intranasal salmon calcitonin (200 IU/day)
Number of subjects: 362
Study: 24373198

Group type: EXPERIMENTAL
Intervention: Sharp scratch
Number of subjects: 192

Group type: COMPARATOR
Intervention: Ready?
Number of subjects: 192
Study: 23989999

Group type: EXPERIMENTAL
Intervention: PESA-IVF + RE-ICSI
Number of subjects: 20

Group type: COMPARATOR
Intervention: PESA-ICSI
Number of subjects: 20
Study: 21676992

Group type: EXPERIMENTAL
Intervention: 40 mg of lurasidone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 120 mg of lurasidone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 15 mg of olanzapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined lurasidone groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0
Study: 20112596

Group type: EXPERIMENTAL
Intervention: 15 mg/day elemental zinc
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo syrup
Number of subjects: 68
Study: 16786405

Group type: EXPERIMENTAL
Intervention: Nullification instructions in a nullification-relevant trial (murder for profit vs. euthanasia)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emotional biases
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nullification instructions
Number of subjects: 0
Study: 15219483

Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (n = 12)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Laparoscopic anterior partial fundoplication (n = 12)
Number of subjects: 24
Study: 11490185

Group type: EXPERIMENTAL
Intervention: Hair shave
Number of subjects: 90

Group type: COMPARATOR
Intervention: No hair shave
Number of subjects: 90
Study: 9129883

Group type: EXPERIMENTAL
Intervention: Beta-blocker therapy
Number of subjects: 3141

Group type: EXPERIMENTAL
Intervention: Vasodilating beta-blockers (e.g., carvedilol)
Number of subjects: 3141

Group type: EXPERIMENTAL
Intervention: Standard beta-blockers (e.g., metoprolol)
Number of subjects: 3141
Study: 8499737

Group type: EXPERIMENTAL
Intervention: HDivIg at 500 mg/kg given over 2 h
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional treatment including phototherapy
Number of subjects: 34
Study: 3677213

Group type: EXPERIMENTAL
Intervention: ASA (1300 mg) alone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: ASA (1300 mg) plus Ranitidine (150 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 10
Study: 31879812

Group type: EXPERIMENTAL
Intervention: 60 mg/kg intravenous tranexamic acid (IV-TXA) before incision (Group B)
Number of subjects: 132

Group type: COMPARATOR
Intervention: 20 mg/kg intravenous tranexamic acid (IV-TXA) before incision (Group A)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: 60 mg/kg intravenous tranexamic acid (IV-TXA)
Number of subjects: 132
Study: 29936239

Group type: EXPERIMENTAL
Intervention: G-ICBT
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: U-ICBT
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: BIB-CBT
Number of subjects: 132

Group type: COMPARATOR
Intervention: WLC
Number of subjects: 132
Study: 27481016

Group type: EXPERIMENTAL
Intervention: 50% nitrous oxide and 50% oxygen (N2O/O2)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Oxygen (O2)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: N2O/O2
Number of subjects: 80

Group type: COMPARATOR
Intervention: O2
Number of subjects: 80
Study: 23530708

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 22968662

Group type: EXPERIMENTAL
Intervention: Distal radius bone graft (group 1)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Iliac crest bone graft (group 2)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups (group 1 and group 2)
Number of subjects: 100
Study: 20446013

Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Penicillin
Number of subjects: 276
Study: 18557720

Group type: EXPERIMENTAL
Intervention: CP-690 550 15 mg BID
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: CP-690 550 30 mg BID
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 16429938

Group type: EXPERIMENTAL
Intervention: aprotinin
Number of subjects: 50

Group type: COMPARATOR
Intervention: normal saline
Number of subjects: 50
Study: 15303108

Group type: EXPERIMENTAL
Intervention: Lifestyle education group (LE‐G)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Substitutional diet with guided physical activity (SD/PA‐G)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Substitutional diet without guided physical activity (SD‐G)
Number of subjects: 90
Study: 11765071

Group type: EXPERIMENTAL
Intervention: Na sucrose octasulfate (Na SOS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 9266888

Group type: EXPERIMENTAL
Intervention: MDI albuterol (360 microg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: NEB albuterol (1.5 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: MDI saline solution placebo
Number of subjects: 11

Group type: COMPARATOR
Intervention: NEB saline solution placebo
Number of subjects: 11
Study: 8418345

Group type: EXPERIMENTAL
Intervention: Microcomputer workstations for writing all inpatient orders
Number of subjects: 5219
Study: 3521619

Group type: EXPERIMENTAL
Intervention: Dried garlic (3 X 198 mg) in Study I
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Dried garlic (3 X 450 mg) in Study II
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 30683623

Group type: EXPERIMENTAL
Intervention: Combination of autogenous and xenogenous bone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sinus membrane elevation without using any substitutes
Number of subjects: 10
Study: 28476062

Group type: EXPERIMENTAL
Intervention: Single radius (SR) TKR
Number of subjects: 105

Group type: COMPARATOR
Intervention: Multiple radius (MR) TKR
Number of subjects: 105
Study: 26802112

Group type: EXPERIMENTAL
Intervention: MI+Education
Number of subjects: 330

Group type: COMPARATOR
Intervention: Education alone
Number of subjects: 330
Study: 23246060

Group type: EXPERIMENTAL
Intervention: CO2 insufflation technique (CO2 group, n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lund technique without CO2 insufflation (Lund group, n = 10)
Number of subjects: 20
Study: 22932944

Group type: EXPERIMENTAL
Intervention: Video-laryngoscopy (VL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Direct laryngoscopy (DL)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both techniques (VL and DL)
Number of subjects: 40
Study: 20399409

Group type: EXPERIMENTAL
Intervention: WIC-based intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 17646564

Group type: EXPERIMENTAL
Intervention: Echinacea purpurea (350 mg single dose)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 14732423

Group type: EXPERIMENTAL
Intervention: Higher frequency of swallowing tobacco juice
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Serum nicotine concentrations
Number of subjects: 68
Study: 12526280

Group type: EXPERIMENTAL
Intervention: Telmisartan 40-80 mg
Number of subjects: 522

Group type: COMPARATOR
Intervention: Enalapril 10-20 mg
Number of subjects: 522
Study: 9815865

Group type: EXPERIMENTAL
Intervention: Lanoteplase (15, 30, 60, or 120 kU/kg)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Lanoteplase (120 kU/kg)
Number of subjects: 602

Group type: COMPARATOR
Intervention: Alteplase
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Lanoteplase
Number of subjects: 602
Study: 7694975

Group type: EXPERIMENTAL
Intervention: Cefmetazole 2 g by intravenous push immediately prior to incision
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cefmetazole 2 g by intravenous push 15 to 60 minutes prior to incision
Number of subjects: 12
Study: 2566222

Group type: EXPERIMENTAL
Intervention: PUVA treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: UVB treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-exposed control (one hand)
Number of subjects: 0
Study: 1209435

Group type: EXPERIMENTAL
Intervention: High doses of vitamins B6, B1 and B12
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 31229593

Group type: EXPERIMENTAL
Intervention: Molecular point‐of‐care test (POCT) for viral and atypical pathogens plus routine real‐time PCR
Number of subjects: 800
Study: 28649870

Group type: EXPERIMENTAL
Intervention: Manual dosing of 10 ml radiolabeled Wet® Original® lubricant
Number of subjects: 5

Group type: COMPARATOR
Intervention: Applicator dosing of 10 ml radiolabeled hydroxyethyl cellulose universal placebo gel
Number of subjects: 5

Group type: COMPARATOR
Intervention: Applicator dosing of 3.5 ml radiolabeled hydroxyethyl cellulose universal placebo gel
Number of subjects: 5
Study: 24782286

Group type: EXPERIMENTAL
Intervention: 0.4 mg/kg pethidine
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: 0.1 μg/kg sufentanil
Number of subjects: 600

Group type: COMPARATOR
Intervention: Both groups (pethidine and sufentanil)
Number of subjects: 600
Study: 23148048

Group type: EXPERIMENTAL
Intervention: 300 g of vegetables and 25 mL PUFA-rich plant oil per day
Number of subjects: 76

Group type: COMPARATOR
Intervention: Information about the benefits of a healthy diet
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (information only)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Intervention group (vegetables and PUFA-rich oil)
Number of subjects: 76
Study: 21616014

Group type: EXPERIMENTAL
Intervention: Point-of-care biochemical marker panel
Number of subjects: 2263

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 2263
Study: 19185463

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (nonresponders)
Number of subjects: 42
Study: 17975459

Group type: EXPERIMENTAL
Intervention: Hands-free crutch
Number of subjects: 80
Study: 15585732

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent
Number of subjects: 257

Group type: COMPARATOR
Intervention: Uncoated stent
Number of subjects: 257
Study: 12575566

Group type: EXPERIMENTAL
Intervention: Baisuifang Oral Liquid (BSF)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Naofukang (Control)
Number of subjects: 65
Study: 9622267

Group type: EXPERIMENTAL
Intervention: Low alcohol beer (0.9%, v/v)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Full-strength beer (5%, v/v)
Number of subjects: 55
Study: 7946935

Group type: EXPERIMENTAL
Intervention: Nimodipine (30 mg three times daily)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg once daily)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combined treatment (Nimodipine and Diazepam)
Number of subjects: 24
Study: 3062266

Group type: EXPERIMENTAL
Intervention: biosynthetic human proinsulin
Number of subjects: 18

Group type: COMPARATOR
Intervention: biosynthetic human NPH insulin (controls)
Number of subjects: 18
Study: 31937906

Group type: EXPERIMENTAL
Intervention: Sleep duration <6 hours
Number of subjects: 1202

Group type: EXPERIMENTAL
Intervention: Sleep duration 8–<9 hours
Number of subjects: 1202

Group type: EXPERIMENTAL
Intervention: Sleep duration
Number of subjects: 1202

Group type: EXPERIMENTAL
Intervention: Weight loss history
Number of subjects: 1202
Study: 31162192

Group type: EXPERIMENTAL
Intervention: Extraventricular drainage plus intraventricular alteplase
Number of subjects: 499

Group type: COMPARATOR
Intervention: Extraventricular drainage plus saline
Number of subjects: 499
Study: 28675814

Group type: EXPERIMENTAL
Intervention: Exposure to violence from teachers
Number of subjects: 3706

Group type: EXPERIMENTAL
Intervention: Exposure to caregiver violence
Number of subjects: 3706

Group type: EXPERIMENTAL
Intervention: Exposure to intimate partner violence (IPV) against female caregivers
Number of subjects: 3706

Group type: EXPERIMENTAL
Intervention: All violence measures
Number of subjects: 3706
Study: 25581701

Group type: EXPERIMENTAL
Intervention: Positive coping strategies (e.g., problem solving, cognitive reframing)
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Negative coping strategies (e.g., fighting, breaking things)
Number of subjects: 645
Study: 22914101

Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance spectroscopy (BIS)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Corrected arm muscle area (CAMA)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Predictive equation 1
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Predictive equation 2
Number of subjects: 79
Study: 20946583

Group type: EXPERIMENTAL
Intervention: Combination of bath PUVA and targeted UVB 308 nm excimer radiation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Bath PUVA alone
Number of subjects: 22
Study: 19772696

Group type: EXPERIMENTAL
Intervention: Coca Cola (2.5 litres per day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Semi-skimmed milk (2.5 litres per day)
Number of subjects: 11
Study: 16420536

Group type: EXPERIMENTAL
Intervention: Elastic compression stockings (pressure as low as 8 mmHg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No stockings
Number of subjects: 0
Study: 15585144

Group type: EXPERIMENTAL
Intervention: High-volume hemofiltration (HVHF) combined with extracorporeal membrane oxygenation (ECMO)
Number of subjects: 8

Group type: COMPARATOR
Intervention: High-volume hemofiltration (HVHF) alone
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-volume hemofiltration (HVHF) with ECMO
Number of subjects: 8

Group type: COMPARATOR
Intervention: High-volume hemofiltration (HVHF)
Number of subjects: 8
Study: 12027046

Group type: EXPERIMENTAL
Intervention: D-fenfluramine (30 mg p.o.)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 9315401

Group type: EXPERIMENTAL
Intervention: Prophylactic ondansetron
Number of subjects: 30

Group type: COMPARATOR
Intervention: Expectant therapy with metoclopramide
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Reduced radiation fields (dog-leg RT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Antiemetic use in expectant therapy groups
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All groups (including ondansetron)
Number of subjects: 30
Study: 8330429

Group type: EXPERIMENTAL
Intervention: Meclofenamate Sodium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naproxen Sodium
Number of subjects: 0
Study: 2872720

Group type: EXPERIMENTAL
Intervention: High-dose fluoxymesterone (1 mg/kg/d)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: High-dose norethandrolone (1 mg/kg/d)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Low-dose fluoxymesterone (0.2 mg/kg/d)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Low-dose norethandrolone (0.2 mg/kg/d)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: High doses of 4 different androgens
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Fluoxymesterone (1 mg/kg/d) for 18 months
Number of subjects: 235
Study: 29193980

Group type: EXPERIMENTAL
Intervention: Estradiol vaginal cream 0.003% (15 μg estradiol; 0.5 g cream), applied vaginally once daily for 2 weeks followed by two applications/week for 10 weeks.
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Estradiol vaginal cream 0.003%
Number of subjects: 576

Group type: COMPARATOR
Intervention: Placebo (0.5 g cream), applied vaginally once daily for 2 weeks followed by two applications/week for 10 weeks.
Number of subjects: 576
Study: 27145084

Group type: EXPERIMENTAL
Intervention: Testosterone administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High 2D:4D group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low 2D:4D group
Number of subjects: 0
Study: 25028375

Group type: EXPERIMENTAL
Intervention: Etanercept (ETN) treatment for 3 years
Number of subjects: 61
Study: 21881530

Group type: EXPERIMENTAL
Intervention: 18-week strength training program (maximal strength training, explosive strength training, golf-specific strength training)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard physical conditioning program for golf (Control Group)
Number of subjects: 10
Study: 20819415

Group type: EXPERIMENTAL
Intervention: Resistance exercise (elastic band exercise at moderate intensity five times per week)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (walking for 60 min at moderate intensity five times per week)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (sedentary lifestyle)
Number of subjects: 44
Study: 18539688

Group type: EXPERIMENTAL
Intervention: Group-based multidisciplinary education programme
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study: 15882537

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg/HCTZ 12.5 mg daily
Number of subjects: 124

Group type: COMPARATOR
Intervention: Nifedipine GITS 60 mg daily
Number of subjects: 124
Study: 12795769

Group type: EXPERIMENTAL
Intervention: Alefacept (0.025 mg/kg, 0.075 mg/kg, or 0.150 mg/kg)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Alefacept
Number of subjects: 229
Study: 12795729

Group type: EXPERIMENTAL
Intervention: Provision of telephone or web‐based provider‐specific information to aid in the selection of a provider
Number of subjects: 1090

Group type: COMPARATOR
Intervention: Control group (assigned to a PCP)
Number of subjects: 1090
Study: 9534499

Group type: EXPERIMENTAL
Intervention: Early labor assessment
Number of subjects: 209

Group type: COMPARATOR
Intervention: Direct admission to hospital
Number of subjects: 209
Study: 7713829

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise (LO)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-intensity exercise (HI)
Number of subjects: 8

Group type: COMPARATOR
Intervention: No exercise (NX)
Number of subjects: 8
Study: 2670029

Group type: EXPERIMENTAL
Intervention: Lyophilised amnion
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Frozen amnion
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fresh amnion
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tissue-culture-maintained amnion
Number of subjects: 40
Study: 790118

Group type: EXPERIMENTAL
Intervention: 15 (R) 15 methyl prostaglandin E2, 150 mug orally every 6 hours for two weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 10
Study: 28866911

Group type: EXPERIMENTAL
Intervention: CBT + booster group
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: CBT only group
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 108
Study: 27899759

Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive treatment aiming for systolic BP 120-140 mmHg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conservative treatment aiming for systolic BP 140-180 mmHg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 100
Study: 24635483

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) for solar keratosis (SK) grade I-II.
Number of subjects: 20
Study: 23809328

Group type: EXPERIMENTAL
Intervention: 0.8g of c9,t11CLA daily for two months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1.6g of c9,t11CLA daily for two months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3.2g of c9,t11CLA daily for two months
Number of subjects: 0
Study: 22352278

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Bromazepam
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 59
Study: 19567487

Group type: EXPERIMENTAL
Intervention: Unsupported upper extremity exercise training (UEET) plus pulmonary rehabilitation (PR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Pulmonary rehabilitation (PR) alone
Number of subjects: 50
Study: 17004019

Group type: EXPERIMENTAL
Intervention: Pharmacist-delivered intervention via a centralised telephone service
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 500
Study: 15099409

Group type: EXPERIMENTAL
Intervention: Supplementation with LC n‐3 PUFA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High‐n‐6 PUFA background diet with fish oil supplementation
Number of subjects: 0
Study: 10827393

Group type: EXPERIMENTAL
Intervention: Streptokinase treatment initiated within the first 1.5 hours (group A)
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Very early fibrinolytic therapy
Number of subjects: 358
Study: 11696900

Group type: EXPERIMENTAL
Intervention: Single Bond (3M Dental Products Division)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Syntac Single-Component (Vivadent)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Prime&Bond 2.1 (Dentsply DeTrey)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tenure Quik with Fluoride (Den-Mat Co.)
Number of subjects: 40
Study: 8138828

Group type: EXPERIMENTAL
Intervention: Adrenocorticotropin (ACTH)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Dexamethasone (DEX)
Number of subjects: 2
Study: 29562906

Group type: EXPERIMENTAL
Intervention: MHFA eLearning course (n = 27)
Number of subjects: 55

Group type: COMPARATOR
Intervention: No-access control group (n = 28)
Number of subjects: 55
Study: 26349772

Group type: EXPERIMENTAL
Intervention: Dexamethasone days 1-3
Number of subjects: 80

Group type: COMPARATOR
Intervention: Dexamethasone day 1
Number of subjects: 80
Study: 23868685

Group type: EXPERIMENTAL
Intervention: Training group (TG) - 4-week training program (3 days/week), consisting of 4 s simultaneous maximal voluntary contractions of elbow flexors and extensors at 90° of the elbow joint, followed by 4 s muscle relaxation (10 repetitions/set, 5 sets/day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 23